Aug 18 (Reuters) - Resonance Health Ltd (RHT) :
- CONTRACTED BY SUN PHARMACEUTICAL INDUSTRIES
- CONTRACTED FOR CLINICAL DRUG TRIAL WORTH A$6.33 MILLION OVER 18 MONTHS
- RESONANCE WILL PROVIDE ITS IMAGING ANALYSIS SERVICES AT VARIOUS TIMEPOINTS THROUGHOUT CLINICAL TRIAL, AMONG OTHERS
News: RHT Resonance Health Contracted For Clinical Drug Trial Worth A$6.33 Million Over 18 Months
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.00M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 454926 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.7¢ | 25836 | 1 |
View Market Depth
| Last trade - 10.47am 18/09/2025 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable